Progressive decrease of N-acetylaspartate to total creatine ratio in the pregenual anterior cingulate cortex in patients with major depressive disorder: Longitudinal 1H-MR spectroscopy study

Acta Radiologica

Volumn 55, Issue 5, 2014, Pages 594-603

  Tae, Woo Suk ^a   Kim, Sam Soo ^a,b   Lee, Kang U K ^a   Nam, Eui Cheol ^a   Koh, Sung Hye ^a  

^a Kangwon National University College of Medicine   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

Anterior cingulate cortex; Longitudinal study; Major depressive disorder; MR spectroscopy; N acetyl aspartate

Indexed keywords

MAGNETIC RESONANCE SPECTROSCOPY;

ANTERIOR CINGULATE CORTICES; LONGITUDINAL STUDY; MAJOR DEPRESSIVE DISORDER; MR SPECTROSCOPY; N-ACETYL ASPARTATE;

PATIENT TREATMENT;

ANTIDEPRESSANT AGENT; CHOLINE; CREATINE; N ACETYLASPARTIC ACID; ASPARTIC ACID; CREATINE PHOSPHATE; N-ACETYLASPARTATE;

ADULT; ANTERIOR CINGULATE; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION INVENTORY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LONGITUDINAL STUDY; MAJOR DEPRESSION; MEDICAL PARAMETERS; METABOLITE; NERVE CELL DEGENERATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREGENUAL ANTERIOR CINGULATE CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TOTAL CREATINE RATIO; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; CINGULATE GYRUS; CROSS-SECTIONAL STUDY; DEPRESSIVE DISORDER, MAJOR; METABOLISM; PROCEDURES;

ADULT; ANTIDEPRESSIVE AGENTS; ASPARTIC ACID; CASE-CONTROL STUDIES; CHOLINE; CREATINE; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; GYRUS CINGULI; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE SPECTROSCOPY; PHOSPHOCREATINE;

EID: 84902138647     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185113502744     Document Type: Article

References (34)

1. Kandel ER. Disorder of mood: depression, mania, anxiety disorder. In: Kandel ER, Schwartz JH, Jessell TM (eds). Principles of neural science. McGraw-Hill, New York; 2000:1213-1216.
2. Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-3105.
3. Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008;358:55-68.
4. Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry 2000;48:813-829.
5. Frodl T, Meisenzahl EM, Zetzsche T, et al. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 2004;65:492-499.
6. MacQueen GM, Campbell S, McEwen BS, et al. Course of illness, hippocampal function, and hippocampal volume in major depression. Proc Natl Acad Sci USA 2003;100:1387-1392.
7. Campbell S, Marriott M, Nahmias C, et al. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004;161:598-607.
8. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004;161:1957-1966.
9. Yildiz-Yesiloglu A, Ankerst DP. Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res 2006;147:1-25.
10. Capizzano AA, Jorge RE, Acion LC, et al. In vivo proton magnetic resonance spectroscopy in patients with mood disorders: a technically oriented review. J Magn Reson Imaging 2007;26:1378-1389.
11. Gillard J, Waldman A, Barker P. Clinical MR neuroimaging: diffusion, perfusion and spectroscopy. Cambridge: Cambridge University Press; 2005:7-26.
12. Charles HC, Lazeyras F, Krishnan KR, et al. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuro-Psychopharmacol Biol Psychiatry 1994;18:1121-1127.
13. Gonul AS, Kitis O, Ozan E, et al. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:120-125.
14. Taki Y, Kinomura S, Awata S, et al. Male elderly subthreshold depression patients have smaller volume of medial part of prefrontal cortex and precentral gyrus compared with age-matched normal subjects: a voxel-based morphometry. J Affect Disord 2005;88:313-320.
15. Tang Y, Wang F, Xie G, et al. Reduced ventral anterior cingulate and amygdala volumes in medication-naive females with major depressive disorder: a voxel-based morphometric magnetic resonance imaging study. Psychiatry Res 2007;156:83-86.
16. Steinberg M. Interviewers guide to the structured clinical interview for DSM-IV dissociative disorders (SCID-D). Washington, DC: American Psychiatric Press; 1994.
17. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
18. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62.
19. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672-679.
20. Vogt BA, Berger GR, Derbyshire SWJ. Structural and Functional dichotomy of human midcingulate cortex. Eur J Neurosci 2003;18:3134-3144.
21. Vogt BA. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci 2005;6:533-544.
22. Vogt BA, Nimchinsky EA, Vogt LJ, et al. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. J Comp Neurol 1995;359:490-506.
23. Eisenberger NI. Using neuroimaging techniques to explore the relationship between social status and health. Soc Cogn Affect Neurosci 2007;2:159-160.
24. Schuff N, Neylan TC, Fox-Bosetti S, et al. Abnormal N-acetylaspartate in hippocampus and anterior cingulate in posttraumatic stress disorder. Psychiatry Res 2008;162:147-157.
25. Hamner MB, Lorberbaum JP, George MS. Potential role of the anterior cingulate cortex in PTSD: review and hypothesis. Depress Anxiety 1999;9:1-14.
26. Ballmaier M, Toga AW, Blanton RE, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004;161:99-108.
27. Sheline YI, Barch DM, Price JL, et al. The default mode network and self-referential processes in depression. Proc Natl Acad Sci U S A 2009;106:1942-1947.
28. Frahm J, Bruhn H, Gyngell ML, et al. Localized highresolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93.
29. Coupland NJ, Ogilvie CJ, Hegadoren KM, et al. Decreased prefrontal myo-inositol in major depressive disorder. Biol Psychiatry 2005;57:1526-1534.
30. Auer DP, Putz B, Kraft E, et al. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000;47:305-313.
31. Kumar A, Thomas A, Lavretsky H, et al. Frontal white matter biochemical abnormalities in late life major depression detected with proton magnetic resonance spectroscopy. Am J Psychiatry 2002;159:630-636.
32. Provencher SW. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001;14:260-264.
33. Jansen JF, Backes WH, Nicolay K, et al. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006;240:318-332.
34. Frye MA, Watzl J, Banakar S, et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology 2007;32:2490-2499.